Neurocrine Biosciences (NBIX) Non Operating Income (2016 - 2021)
Historic Non Operating Income for Neurocrine Biosciences (NBIX) over the last 12 years, with Q3 2021 value amounting to -$14.0 million.
- Neurocrine Biosciences' Non Operating Income fell 937.5% to -$14.0 million in Q3 2021 from the same period last year, while for Sep 2021 it was -$36.4 million, marking a year-over-year decrease of 16.24%. This contributed to the annual value of -$25.7 million for FY2019, which is 7099.11% down from last year.
- According to the latest figures from Q3 2021, Neurocrine Biosciences' Non Operating Income is -$14.0 million, which was down 937.5% from -$5.3 million recorded in Q2 2021.
- In the past 5 years, Neurocrine Biosciences' Non Operating Income ranged from a high of $17.7 million in Q2 2019 and a low of -$31.7 million during Q3 2019
- Over the past 5 years, Neurocrine Biosciences' median Non Operating Income value was -$4.3 million (recorded in 2018), while the average stood at -$5.7 million.
- In the last 5 years, Neurocrine Biosciences' Non Operating Income skyrocketed by 53585.32% in 2019 and then plummeted by 115000.0% in 2020.
- Over the past 5 years, Neurocrine Biosciences' Non Operating Income (Quarter) stood at -$4.9 million in 2017, then skyrocketed by 38.0% to -$3.1 million in 2018, then plummeted by 231.08% to -$10.1 million in 2019, then fell by 26.22% to -$12.8 million in 2020, then decreased by 9.38% to -$14.0 million in 2021.
- Its Non Operating Income was -$14.0 million in Q3 2021, compared to -$5.3 million in Q2 2021 and -$4.3 million in Q1 2021.